576 related articles for article (PubMed ID: 22673056)
21. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
Robinson BM; Kennedy C; McLean J; McCaughan BC
J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.
Liao WY; Chen JH; Wu M; Shih JY; Chen KY; Ho CC; Yang JC; Yu CJ
Clin Lung Cancer; 2013 Jul; 14(4):418-24. PubMed ID: 23291258
[TBL] [Abstract][Full Text] [Related]
24. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
Ito T; Murakawa T; Sato H; Tanabe A; Maekawa M; Yoshida Y; Fukayama M; Nakajima J
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):633-8. PubMed ID: 22740516
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
26. [Vascular invasion by tumor in the absence of regional lymph node metastases in patients with locally advanced non-small cell lung cancer].
Akopov AL; Dvorakovskaia IV
Vopr Onkol; 2004; 50(4):417-20. PubMed ID: 15605763
[TBL] [Abstract][Full Text] [Related]
27. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
28. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
[TBL] [Abstract][Full Text] [Related]
30. Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.
Zeliadt SB; Sekaran NK; Hu EY; Slatore CC; Au DH; Backhus L; Wu DY; Crawford J; Lyman GH; Dale DC
J Thorac Oncol; 2011 Oct; 6(10):1726-32. PubMed ID: 21857253
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.
Shoji F; Haro A; Yoshida T; Ito K; Morodomi Y; Yano T; Maehara Y
Ann Thorac Surg; 2010 Mar; 89(3):864-9. PubMed ID: 20172144
[TBL] [Abstract][Full Text] [Related]
32. Intratumoral lymphatic vessel involvement is an invasive indicator of completely resected pathologic stage I non-small cell lung cancer.
Harada M; Hato T; Horio H
J Thorac Oncol; 2011 Jan; 6(1):48-54. PubMed ID: 21079523
[TBL] [Abstract][Full Text] [Related]
33. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
[TBL] [Abstract][Full Text] [Related]
34. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
Hung JJ; Hsu WH; Hsieh CC; Huang BS; Huang MH; Liu JS; Wu YC
Thorax; 2009 Mar; 64(3):192-6. PubMed ID: 19252018
[TBL] [Abstract][Full Text] [Related]
35. Results of T4 surgical cases in the Japanese Lung Cancer Registry Study: should mediastinal fat tissue invasion really be included in the T4 category?
Watanabe S; Asamura H; Miyaoka E; Okumura M; Yoshino I; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Sawabata N; Yokoi K;
J Thorac Oncol; 2013 Jun; 8(6):759-65. PubMed ID: 23608818
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less.
Kobayashi N; Toyooka S; Soh J; Ichimura K; Yanai H; Suehisa H; Ichihara S; Yamane M; Aoe M; Sano Y; Date H
J Thorac Oncol; 2007 Sep; 2(9):808-12. PubMed ID: 17805057
[TBL] [Abstract][Full Text] [Related]
37. The presence of mutations in epidermal growth factor receptor gene is not a prognostic factor for long-term outcome after surgical resection of non-small-cell lung cancer.
Kim YT; Seong YW; Jung YJ; Jeon YK; Park IK; Kang CH; Kim JH
J Thorac Oncol; 2013 Feb; 8(2):171-8. PubMed ID: 23287850
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
39. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
